UFP TECHNOLOGIES INC (UFPT) Q3 2025 10-Q Quarterly Report
Filed: Nov 7, 2025Period ending Sep 30, 2025
Health Care
Surgical & Medical Instruments & ApparatusSEC EDGAR UFP TECHNOLOGIES INC (UFPT) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 7, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
UFP TECHNOLOGIES INC Q3 2025 10-Q Analysis
Risk Factors
- • NEW Labor risk: AJR labor eligibility review caused significant turnover and $15M unfulfilled 2025 orders, reducing productivity and efficiency for medical device manufacturing
- • UPDATED Tariff risk: US tariffs increasing material costs by ~$6M annually, potential supply chain disruptions, uncertain impact on demand from customers paying tariffs
- • Regulatory risk: Enactment of OBBBA tax law July 2025 with immaterial impact on tax expense but updating corporate tax provisions under ASC 740
- • Operational risk: AJR labor inefficiencies in 2025 reducing gross margin to 27.7% Q3 2025 from 28.6% prior year, expected gradual improvement Q4 2025
- • Financial risk: $146.1M long-term debt with $125M term loan, $150M revolving credit, 5.5% weighted average interest, compliance with covenants through June 2029 maturity
UFP TECHNOLOGIES INC Q3 2025 Quarterly FinancialsXBRL
Revenue
$155M
▲ +6.5% YoY▲ +2.2% QoQ
Net Income
$16M
▲ +0.1% YoY▼ -4.6% QoQ
Gross Margin
27.7%
▼ -95bp YoY▼ -115bp QoQ
Operating Margin
15.1%
▼ -193bp YoY▼ -97bp QoQ
Net Margin
10.6%
▼ -67bp YoY▼ -76bp QoQ
ROE
4.1%
Total Assets
$653M
EPS (Diluted)
$2.10
▼ -0.5% YoY▼ -5.0% QoQ
Operating Cash Flow
$36M
▲ +81.4% YoY▲ +41.8% QoQ
Source: XBRL data from UFP TECHNOLOGIES INC Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on UFP TECHNOLOGIES INC
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.